Cargando…

Appraisal of novel azomethine–thioxoimidazolidinone conjugates as ecto-5′-nucleotidase inhibitors: synthesis and molecular docking studies

Purinergic signaling is regulated by a group of extracellular enzymes called ectonucleotidases. One of its members i.e., ecto-5′-nucleotidase (h-e5′NT) is involved in the final step of the enzymatic hydrolysis cascade that is the conversion of adenosine monophosphate (AMP) to adenosine and therefore...

Descripción completa

Detalles Bibliográficos
Autores principales: Channar, Pervaiz Ali, Bano, Sehrish, Hassan, Sidra, Perveen, Fouzia, Saeed, Aamer, Mahesar, Parvez Ali, Khan, Imtiaz Ali, Iqbal, Jamshed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194930/
https://www.ncbi.nlm.nih.gov/pubmed/35765454
http://dx.doi.org/10.1039/d2ra02675a
_version_ 1784726852913332224
author Channar, Pervaiz Ali
Bano, Sehrish
Hassan, Sidra
Perveen, Fouzia
Saeed, Aamer
Mahesar, Parvez Ali
Khan, Imtiaz Ali
Iqbal, Jamshed
author_facet Channar, Pervaiz Ali
Bano, Sehrish
Hassan, Sidra
Perveen, Fouzia
Saeed, Aamer
Mahesar, Parvez Ali
Khan, Imtiaz Ali
Iqbal, Jamshed
author_sort Channar, Pervaiz Ali
collection PubMed
description Purinergic signaling is regulated by a group of extracellular enzymes called ectonucleotidases. One of its members i.e., ecto-5′-nucleotidase (h-e5′NT) is involved in the final step of the enzymatic hydrolysis cascade that is the conversion of adenosine monophosphate (AMP) to adenosine and therefore, involves the regulation of adenosine level in extracellular space. The overexpression of h-e5′NT has been observed in various pathological conditions such as hypoxia, inflammation and cancers, and led to various complications. Hence, the identification of a potent as well as selective inhibitor of h-e5′NT is of greater importance in therapeutic treatment of various diseases. Azomethine-thioxoimidazolidinone derivatives were studied for their inhibition potential against e5′NT enzyme along with cytotoxic potential against cancer cell lines possessing overexpression of e5′NT enzyme. The derivative (E)-3-((4-((3-methoxybenzyl)oxy)benzylidene)amino)-2-thioxoimidazolidin-4-one (4g) displayed selective and significant inhibition towards h-e5′NT with an IC(50) value of 0.23 ± 0.08 μM. While two other derivatives i.e., (E)-3-(((5-bromothiophen-2-yl)methylene)amino)-2-thioxoimidazolidin-4-one (4b) and 2-thioxo-3-((3,4,5-trimethoxybenzylidene)amino)imidazolidin-4-one (4e), exhibited non-selective potent inhibitory behavior against both human and rat enzymes. Moreover, these derivatives (4b, 4e and 4g) were further investigated for their effect on the expression of h-e5′NT using quantitative real time polymerase chain reaction. Additionally, molecular docking and DFT studies were also performed to determine the putative binding mode of potent inhibitors within the enzyme active site. HOMO, LUMO, ΔE, and molecular electrostatic potential maps were computed by DFT and the charge transfer regions within the molecules were identified to find out the regions for electrophilic and nucleophilic attack.
format Online
Article
Text
id pubmed-9194930
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Royal Society of Chemistry
record_format MEDLINE/PubMed
spelling pubmed-91949302022-06-27 Appraisal of novel azomethine–thioxoimidazolidinone conjugates as ecto-5′-nucleotidase inhibitors: synthesis and molecular docking studies Channar, Pervaiz Ali Bano, Sehrish Hassan, Sidra Perveen, Fouzia Saeed, Aamer Mahesar, Parvez Ali Khan, Imtiaz Ali Iqbal, Jamshed RSC Adv Chemistry Purinergic signaling is regulated by a group of extracellular enzymes called ectonucleotidases. One of its members i.e., ecto-5′-nucleotidase (h-e5′NT) is involved in the final step of the enzymatic hydrolysis cascade that is the conversion of adenosine monophosphate (AMP) to adenosine and therefore, involves the regulation of adenosine level in extracellular space. The overexpression of h-e5′NT has been observed in various pathological conditions such as hypoxia, inflammation and cancers, and led to various complications. Hence, the identification of a potent as well as selective inhibitor of h-e5′NT is of greater importance in therapeutic treatment of various diseases. Azomethine-thioxoimidazolidinone derivatives were studied for their inhibition potential against e5′NT enzyme along with cytotoxic potential against cancer cell lines possessing overexpression of e5′NT enzyme. The derivative (E)-3-((4-((3-methoxybenzyl)oxy)benzylidene)amino)-2-thioxoimidazolidin-4-one (4g) displayed selective and significant inhibition towards h-e5′NT with an IC(50) value of 0.23 ± 0.08 μM. While two other derivatives i.e., (E)-3-(((5-bromothiophen-2-yl)methylene)amino)-2-thioxoimidazolidin-4-one (4b) and 2-thioxo-3-((3,4,5-trimethoxybenzylidene)amino)imidazolidin-4-one (4e), exhibited non-selective potent inhibitory behavior against both human and rat enzymes. Moreover, these derivatives (4b, 4e and 4g) were further investigated for their effect on the expression of h-e5′NT using quantitative real time polymerase chain reaction. Additionally, molecular docking and DFT studies were also performed to determine the putative binding mode of potent inhibitors within the enzyme active site. HOMO, LUMO, ΔE, and molecular electrostatic potential maps were computed by DFT and the charge transfer regions within the molecules were identified to find out the regions for electrophilic and nucleophilic attack. The Royal Society of Chemistry 2022-06-14 /pmc/articles/PMC9194930/ /pubmed/35765454 http://dx.doi.org/10.1039/d2ra02675a Text en This journal is © The Royal Society of Chemistry https://creativecommons.org/licenses/by/3.0/
spellingShingle Chemistry
Channar, Pervaiz Ali
Bano, Sehrish
Hassan, Sidra
Perveen, Fouzia
Saeed, Aamer
Mahesar, Parvez Ali
Khan, Imtiaz Ali
Iqbal, Jamshed
Appraisal of novel azomethine–thioxoimidazolidinone conjugates as ecto-5′-nucleotidase inhibitors: synthesis and molecular docking studies
title Appraisal of novel azomethine–thioxoimidazolidinone conjugates as ecto-5′-nucleotidase inhibitors: synthesis and molecular docking studies
title_full Appraisal of novel azomethine–thioxoimidazolidinone conjugates as ecto-5′-nucleotidase inhibitors: synthesis and molecular docking studies
title_fullStr Appraisal of novel azomethine–thioxoimidazolidinone conjugates as ecto-5′-nucleotidase inhibitors: synthesis and molecular docking studies
title_full_unstemmed Appraisal of novel azomethine–thioxoimidazolidinone conjugates as ecto-5′-nucleotidase inhibitors: synthesis and molecular docking studies
title_short Appraisal of novel azomethine–thioxoimidazolidinone conjugates as ecto-5′-nucleotidase inhibitors: synthesis and molecular docking studies
title_sort appraisal of novel azomethine–thioxoimidazolidinone conjugates as ecto-5′-nucleotidase inhibitors: synthesis and molecular docking studies
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194930/
https://www.ncbi.nlm.nih.gov/pubmed/35765454
http://dx.doi.org/10.1039/d2ra02675a
work_keys_str_mv AT channarpervaizali appraisalofnovelazomethinethioxoimidazolidinoneconjugatesasecto5nucleotidaseinhibitorssynthesisandmoleculardockingstudies
AT banosehrish appraisalofnovelazomethinethioxoimidazolidinoneconjugatesasecto5nucleotidaseinhibitorssynthesisandmoleculardockingstudies
AT hassansidra appraisalofnovelazomethinethioxoimidazolidinoneconjugatesasecto5nucleotidaseinhibitorssynthesisandmoleculardockingstudies
AT perveenfouzia appraisalofnovelazomethinethioxoimidazolidinoneconjugatesasecto5nucleotidaseinhibitorssynthesisandmoleculardockingstudies
AT saeedaamer appraisalofnovelazomethinethioxoimidazolidinoneconjugatesasecto5nucleotidaseinhibitorssynthesisandmoleculardockingstudies
AT mahesarparvezali appraisalofnovelazomethinethioxoimidazolidinoneconjugatesasecto5nucleotidaseinhibitorssynthesisandmoleculardockingstudies
AT khanimtiazali appraisalofnovelazomethinethioxoimidazolidinoneconjugatesasecto5nucleotidaseinhibitorssynthesisandmoleculardockingstudies
AT iqbaljamshed appraisalofnovelazomethinethioxoimidazolidinoneconjugatesasecto5nucleotidaseinhibitorssynthesisandmoleculardockingstudies